REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation
IAVASC
1 other identifier
observational
250
1 country
1
Brief Summary
The team hypothesizes that fully automatic analysis of AAA could provide increased performance (decreased duration of segmentation with increased reproducibility and decreased inter and intraobserver variability) to detect aortic aneurysmal sac enlargement (volumes and diameters) and predict the risk of complications during the procedure and during follow-up (MAE, MACE, MALE, Stroke) compared to standard methods of measurement relying on approximate maximum sac diameter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2024
CompletedFirst Submitted
Initial submission to the registry
May 31, 2024
CompletedFirst Posted
Study publicly available on registry
June 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2024
CompletedJune 13, 2024
May 1, 2024
6 months
May 31, 2024
June 11, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
global volume measure of the aneurysm
global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.
6 months before surgery
global volume measure of the aneurysm
global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.
Day 3
global volume measure of the aneurysm
global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.
Month 3
global volume measure of the aneurysm
global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.
Month 6
global volume measure of the aneurysm
global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.
Month 12
Secondary Outcomes (15)
lumen volume measure of the aneurysm
6 months before surgery
lumen volume measure of the aneurysm
Day 3
lumen volume measure of the aneurysm
Month 3
lumen volume measure of the aneurysm
Month 6
lumen volume measure of the aneurysm
Month 12
- +10 more secondary outcomes
Study Arms (1)
Abdominal Aortic Aneurysm (AAA) treated with EndoVascular Aneurysm Repair (EVAR)
Male or female ≥18 years of age with AAA treated with EVAR between ≥50mm or ≥5mm increase in 6 months. The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate. He is available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry
Interventions
CTscans will be analyzed pre-operatively (6 months before intervention) and post-operatively with an early control scan (up to one-month post-EVAR), compared to a 3, 6 and 12-month control scan by system develop by Nurea
CTscans will be analyzed pre-operatively (6 months before intervention) and post-operatively with an early control scan (up to one-month post-EVAR), compared to a 3, 6 and 12-month control scan by an hospital practitioner
Eligibility Criteria
The patient came to the vascular surgery unit for his post-operative follow-up visit who have had surgery for Abdominal Aortic Aneurysm
You may qualify if:
- Male or female ≥18 years of age
- AAA treated with EVAR between
- ≥50mm
- or ≥5mm increase in 6 months
- The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate.
- Available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry
You may not qualify if:
- Advancing Alzheimer's disease or socially dependent patient
- Opposition to the use of their data for this research
- Life expectancy supposed to be inferior to 2 years
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bordeauxlead
- Nureacollaborator
Study Sites (1)
Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux
Bordeaux, 33076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric DUCASSE, MD, PhD
University Hospital, Bordeaux
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2024
First Posted
June 11, 2024
Study Start
January 30, 2024
Primary Completion
July 15, 2024
Study Completion
July 15, 2024
Last Updated
June 13, 2024
Record last verified: 2024-05